Remove 2011 Remove Diabetes Remove Documentation
article thumbnail

STAT+: Pharmalittle: We’re reading about Novo targeting compounded obesity drugs, an Amgen ‘at risk’ launch, and more

STAT

regulators in 2011. The FDA still has to make a decision on whether to officially place semaglutide on the lists. Court of Appeals for the Federal Circuit rejected Regeneron’s request to block the launch during its appeal of a related decision for Amgen in a patent case in West Virginia. Last year, the drug generated $5.89

article thumbnail

NHC Responds to Joint CMS–ASTP/ONC RFI on Improving Health Technology

Putting Patients First Blog

Developers should be required to: Conduct inclusive usability testing with older adults, people with disabilities, caregivers, and individuals with limited English proficiency; Share documentation of feedback collection and integration; and Comply with Section 508 and WCAG 2.1 Incentivizing the use of HL7 FHIR, OAuth 2.0,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NHC’s comments in response to the 2025 Notice of Benefit and Payment Parameters (NBPP)

Putting Patients First Blog

Addressing the critical issue faced by States and consumers, the previous policy, which required States to defray the cost of benefits mandated after December 31, 2011, but not subjecting some benefits included in EHB-benchmark plans to defrayal requirements, led to confusion and operational challenges. Retrieved from https ://w ww.

article thumbnail

Taming cardiovascular risk: the promise of LDL cholesterol lowering therapeutics

European Pharmaceutical Review

Obesity, metabolic syndrome, diabetes epidemic is global, so that aggravates cardiovascular risk… we are seeing a marked acceleration of heart disease deaths, and we need to find new therapies to make a difference. Michael served as President of the National Lipid Association from 2010 to 2011. There are “many reasons” he shared.

article thumbnail

Pharmaceutical Compounding Calculations, Part Two–Bulk Drugs

PharmaTech

It builds on drug calculations topics previously described (1), including guidance documents (2–5). FDA guidance documents illustrate labeling salt drugs and associated active moieties. cardiac, immunogenicity, hepatic, diabetes) affecting compounding and drug dosage must be known. Drug Z, 50 mg. 100 capsules.

article thumbnail

Lasers for Thyroid Tissue Regeneration

The Thyroid Pharmacist

This group also performed a randomized, larger placebo-controlled trial of 43 patients in 2011. This happens from nerve damage (temporary or permanent) due to illness (for instance, diabetes, shingles, multiple sclerosis, inflammatory disorders) or injury. [24] Thus, this therapy may also be helpful for reducing goiter size.

Dosage 98
article thumbnail

Air Quality and Hashimoto’s – Is the Air You’re Breathing Making You Sick?

The Thyroid Pharmacist

Feel free to use my own health timeline as a guideline to document your health journey. Curr Opin Endocrinol Diabetes Obes. Published September 12, 2011. As you add your symptoms to a health history timeline, reflect on what season it was when your allergy or thyroid symptoms worsened. BAAQMD website. Published March 2014.